drugset / Trial / NCT02399163

Evaluation of Oral Hygiene Products in an In Situ Caries Model

NCT02399163 ↗

Completed 80 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindTreatment

Summary

The study will evaluate and compare the potential anti-caries efficacy of a test regimen: placebo (fluoride free) toothpaste (twice daily use) plus fluoride mouthwash (once daily use), in comparison with brushing with a placebo toothpaste alone (twice daily use), to remineralize previously demineralized enamel specimens, as measured by Surface MicroHardness Recovery (%SMHR). This will be a single center, randomized, laboratory analyst blinded, placebo, four treatment, cross-over study in healthy participants. Participants will be assessed at baseline and at the beginning and end of each treatment visit to monitor clinical efficacy and safety.

Timeline

Start
2015-04
Primary completion
2015-07
Completion
2015-08

Outcome

Met primary endpoint

registry p <0.0001; Mean Difference (Net) 16.76 (95% CI 11.061 to 22.454); ANCOVA NCT02399163 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium fluoride Unknown 220 ppm —
Subject sodium fluoride Unknown 1150 ppm —

Indications